Please provide your email address to receive an email when new articles are posted on . Anti-melanoma differentiation-associated gene 5 antibodies were observed in the sera of European patients with ...

A recent study describes the success of using lenabasum, a cannabinoid receptor type 2 (CB2) agonist that triggers the resolution of inflammation, to treat amyopathic dermatomyositis. This phase 2 ...

Dermatomyositis is a rare autoimmune disease that typically affects the skin, muscle and respiratory system. Patients with dermatomyositis usually require prompt treatment with intense ...

Commercial autoantibody testing showed no significant differences in the prevalence of myositis-specific and myositis-associated autoantibodies between patients with classic dermatomyositis and those ...

A recent study in the Journal of Investigative Dermatology describes the success of using lenabasum, a cannabinoid receptor type 2 (CB2) agonist that triggers the resolution of inflammation, to treat ...

Please provide your email address to receive an email when new articles are posted on . Juvenile dermatomyositis challenges rheumatologists to accurately assess not only the skin but also pulmonary ...

The researchers suggested that the myopathies may be preceded by a disease of the skin but more recently, cases of amyopathic dermatomyositis have been observed, where only the skin and not the ...

Dermatomysoitis is a rare inflammatory condition in which the muscles get inflamed. It can affect anyone from children to adults. It is common in children between 5 to 15 years of age and in adults it ...

Dermatomyositis is a multisystem autoimmune connective tissue disease that is most often characterized by a symmetric proximal extensor inflammatory myopathy, a characteristic violaceous cutaneous ...

According to a phase 2 clinical trial published in the Journal of Investigative Dermatology, this well-tolerated medication offers the first oral therapeutic option specifically for the skin-only form ...

Children with a rare, debilitating muscle disease could benefit from the findings of new research by experts at UCL and Great Ormond Street Hospital (GOSH). Significantly more adults with ...